Blog
BeCytes Biotechnologies
Liver models to test new drugs based on 2D cell culture of primary hepatocytes and the use of experimental animal models are slow, costly, and have significant biases. BeCytes [...]
Published On: 27/05/2024-
Drug-induced liver injury (DILI) has fatal consequences, both personally and economically. Its health impact ranges from mild liver enzyme elevation to severe liver failure. In the drug development process, [...]
Published On: 10/05/2024 -
Regulatory agencies, such as the Food and Drug Administration (FDA), are moving towards reducing animal testing and encouraging the use of New Alternative Methodologies (NAMs) in pharmaceutical research. NAMs [...]
Published On: 15/04/2024 -
Experts talks: In vitro liver models for reliable predictions in preclinical stages The advent of new alternative methodologies marks a significant stride forward in biomedical research, enabling safer and [...]
Published On: 03/04/2024 -
Organoids vs Spheroids: 3 important differences The evolution from 2D monolayer cultures towards 3D cell cultures has marked a crucial advance for modeling human development and diseases. Since the [...]
Published On: 12/03/2024 
Human hepatic stellate cells (HSCs) are liver-specific mesenchymal cells located in the space of Disse, between the endothelial cells of the sinusoid and the hepatocytes. Although HSCs represent only 5–10% [...]
Published On: 27/02/2024
